H.R. 10369

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

4 cosponsors

Where it stands

Introduced Sep 14
Committee Now
House of Representatives —
Senate —
Law —

Introduced Sep 14
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Sep 14)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

This Act may be cited as the Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026.

Sec. 2. Medicare part D pharmacy benefit manager reforms

Sec. 3. Medicare Advantage pharmacy benefit manager requirements

Sec. 4. Commercial health plan transparency requirements